Lista de obras -

A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells.

artículo científico publicado en 2011

A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren's Syndrome

artículo científico publicado en 2015

Activation-Induced Cytidine Deaminase Expression in Follicular Dendritic Cell Networks and Interfollicular Large B Cells Supports Functionality of Ectopic Lymphoid Neogenesis in Autoimmune Sialoadenitis and MALT Lymphoma in Sjogren's Syndrome

artículo científico publicado en 2007

Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndrome

artículo científico publicado en 2012

CXCL13, CCL21, and CXCL12 Expression in Salivary Glands of Patients with Sjogren's Syndrome and MALT Lymphoma: Association with Reactive and Malignant Areas of Lymphoid Organization

artículo científico publicado en 2008

Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry ⬇️

artículo científico publicado en 2018

Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome? ⬇️

artículo científico publicado en 2014

Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy ⬇️

artículo científico publicado en 2017

Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry

artículo científico publicado en 2015

Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.

artículo científico publicado en 2017

Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines ⬇️

artículo científico publicado en 2016

Health-related utility values of patients with primary Sjögren's syndrome and its predictors

artículo científico publicado en 2013

Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression.

artículo científico publicado en 2018

Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate

artículo científico publicado en 2004

Inducible tertiary lymphoid structures, autoimmunity, and exocrine dysfunction in a novel model of salivary gland inflammation in C57BL/6 mice

artículo científico publicado en 2012

Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus.

artículo científico publicado en 2018

Interleukin-18 as a potential therapeutic target in chronic autoimmune/inflammatory conditions

artículo científico publicado en 2007

Involvement of Autoimmunity in the Pathogenesis of Aggressive Periodontitis ⬇️

artículo científico publicado el 12 de octubre de 2010

Isoform-selective induction of human p110δ PI3K expression by TNFα: identification of a new and inducible PIK3CD promoter ⬇️

artículo científico publicado el 1 de mayo de 2012

Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis

artículo científico publicado en 2010

Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndrome.

artículo científico publicado en 2019

Physical activity but not sedentary activity is reduced in primary Sjögren's syndrome ⬇️

scientific article published on 24 December 2016

Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome. ⬇️

artículo científico publicado en 2017

Relationship of Interleukin-12 and Interleukin-13 imbalance with class-specific rheumatoid factors and anticardiolipin antibodies in systemic lupus erythematosus ⬇️

artículo científico publicado el 1 de mayo de 2003

Resistance to rituximab therapy and local BAFF overexpression in Sjögren's syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphoma

artículo científico publicado en 2008

Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome - Capturing the discrepancy ⬇️

artículo científico publicado en 2016

Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide ⬇️

artículo científico publicado el 27 de julio de 2012

The TRACTISS protocol: a randomised double blind placebo controlled clinical trial of anti-B-cell therapy in patients with primary Sjögren's Syndrome ⬇️

scientific article published on 17 January 2014

The role of viruses in autoreactive B cell activation within tertiary lymphoid structures in autoimmune diseases ⬇️

artículo científico publicado el 28 de junio de 2013

Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphoma

scientific article published on 22 September 2020

Lista de obras de

A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells.

A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren's Syndrome

Activation-Induced Cytidine Deaminase Expression in Follicular Dendritic Cell Networks and Interfollicular Large B Cells Supports Functionality of Ectopic Lymphoid Neogenesis in Autoimmune Sialoadenitis and MALT Lymphoma in Sjogren's Syndrome

Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndrome

CXCL13, CCL21, and CXCL12 Expression in Salivary Glands of Patients with Sjogren's Syndrome and MALT Lymphoma: Association with Reactive and Malignant Areas of Lymphoid Organization

Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry ⬇️

Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome? ⬇️

Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy ⬇️

Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry

Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.

Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines ⬇️

Health-related utility values of patients with primary Sjögren's syndrome and its predictors

Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression.

Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate

Inducible tertiary lymphoid structures, autoimmunity, and exocrine dysfunction in a novel model of salivary gland inflammation in C57BL/6 mice

Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus.

Interleukin-18 as a potential therapeutic target in chronic autoimmune/inflammatory conditions

Involvement of Autoimmunity in the Pathogenesis of Aggressive Periodontitis ⬇️

Isoform-selective induction of human p110δ PI3K expression by TNFα: identification of a new and inducible PIK3CD promoter ⬇️

Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis

Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndrome.

Physical activity but not sedentary activity is reduced in primary Sjögren's syndrome ⬇️

Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome. ⬇️

Relationship of Interleukin-12 and Interleukin-13 imbalance with class-specific rheumatoid factors and anticardiolipin antibodies in systemic lupus erythematosus ⬇️

Resistance to rituximab therapy and local BAFF overexpression in Sjögren's syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphoma

Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome - Capturing the discrepancy ⬇️

Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide ⬇️

The TRACTISS protocol: a randomised double blind placebo controlled clinical trial of anti-B-cell therapy in patients with primary Sjögren's Syndrome ⬇️

The role of viruses in autoreactive B cell activation within tertiary lymphoid structures in autoimmune diseases ⬇️

Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphoma